
Analysts Viewpoint
ORIC (ORIC Pharmaceuticals Inc) may reap gains as insiders became active recently
ORIC Pharmaceuticals Inc’s filing revealed that its Chief Financial Officer Piscitelli Dominic unloaded Company’s shares for reported $0.2 million on